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Background
Rheumatoid arthritis (RA), systemic lupus erythemato-
sus (SLE) and systemic sclerosis (SSc) commonly involve
the cardiovascular system, and are associated with high
morbidity and mortality. Mechanisms of cardiovascular
disease (CVD) involvement in these clinical entities are
not fully understood. Furthermore, little is known about
myocardial structure and function in these inflammatory
arthropathies. Late gadolinium enhancement (LGE) car-
diovascular magnetic resonance (CMR) imaging is a tool
for noninvasive evaluation of myocardial fibrosis that
has the advantage over other imaging techniques of
being able to directly visualise both ischaemic and non-
ischaemic patterns of injury, and has prognostic signifi-
cance. The purpose of this study was to assess the fre-
quency and pattern of LGE in RA, SLE and SSc patients
without any known CVD using CMR and to determine
its relation to disease duration, vascular function (aortic
distensibility; pulse wave velocity) and left ventricular
(LV) systolic function (LV ejection fraction; mid short
axis circumferential systolic strain).
Methods
59 RA patients (42 female, mean age 53 ± 12), 29 SLE
patients (28 female, mean age 42 ± 10), 18 SSc patients
(17 female, mean age 55 ± 10), 45 normal controls (38
female, mean age 44 ± 12), and 14 controls with cardiovas-
cular risk factors [CVRFs] (11 female, mean age 52 ± 8)
underwent CMR at 1.5 Tesla. All patients with previously
known CVD were excluded. Biventricular volumes and
function, presence and pattern of LGE, myocardial strain
and vascular function were assessed by CMR.
Results
LGE was found to occur in 46% of RA, 31% of SLE and
50% of SSc patients compared to 9% of normal controls
and 21% of controls with CVRFs (p<0.001). The patterns of
LGE are presented in Table 1. Presence of LGE correlated
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RA N=59 SLE N=29 SSC N=18 P Value
Frequency of LGE 4 (8.9) 3 (21.4) 27 (45.8) 9 (31.0) 9 (50.0) <0.001
Pattern of LGE Basal inferolateral LGE Lateral wall
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with disease duration (Rs= 0.33; p<0.001), myocardial strain
(Rs= 0.29; p<0.001), and total aortic pulse wave velocity
(Rs= 0.72; p<0.001).
Conclusions
CMR demonstrates an increased burden of both ischaemic
and non-ischaemic fibrosis in patients with inflammatory
systemic diseases with no known CVD. Increased myocar-
dial fibrosis may contribute to the poor cardiovascular
outcomes in this group of patients. LGE in RA, SLE and
SSc correlates with increasing disease duration, impaired
myocardial strain, and increased pulse wave velocity.
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Figure 1 Different patterns of LGE in patients with inflammatory arthropathies (Top left: control with no LGE; top right: SSc patient with basal
inferolateral wall LGE; bottom left: SLE patient with lateral midwall/subepicardial LGE; bottom right: RA patient with myocardial infarction
(subendocardial LGE).
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